Holdings of the Fund as of 11/22/2024
Total Number of Holdings (excluding cash): 50
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
25,504 |
$1,501,420.48 |
8.91% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
7,681 |
$1,191,860.77 |
7.07% |
AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
6,489 |
$1,148,228.55 |
6.81% |
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
43,914 |
$1,126,394.10 |
6.68% |
Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
10,755 |
$1,066,680.90 |
6.33% |
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
8,063 |
$727,201.97 |
4.31% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
52,729 |
$704,986.73 |
4.18% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
5,651 |
$688,517.84 |
4.08% |
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,693 |
$631,302.77 |
3.75% |
Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
3,471 |
$614,228.16 |
3.64% |
Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
4,661 |
$590,408.87 |
3.50% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
1,908 |
$561,963.24 |
3.33% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
663 |
$495,930.63 |
2.94% |
Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
3,111 |
$491,226.90 |
2.91% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
2,107 |
$412,487.39 |
2.45% |
Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals |
26,658 |
$407,334.24 |
2.42% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
538 |
$397,044.00 |
2.36% |
Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
899 |
$303,637.25 |
1.80% |
Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
21,875 |
$292,250.00 |
1.73% |
Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,898 |
$238,483.70 |
1.41% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
5,368 |
$191,154.48 |
1.13% |
Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
6,301 |
$181,342.78 |
1.08% |
Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,708 |
$181,692.00 |
1.08% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
6,065 |
$170,244.55 |
1.01% |
Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,982 |
$168,172.70 |
1.00% |
Corcept Therapeutics Incorporated |
CORT |
218352102 |
Pharmaceuticals |
2,506 |
$144,195.24 |
0.86% |
Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
2,886 |
$134,083.56 |
0.80% |
TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
3,766 |
$132,073.62 |
0.78% |
Arcellx, Inc. |
ACLX |
03940C100 |
Biotechnology |
1,287 |
$116,396.28 |
0.69% |
ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
5,111 |
$108,250.98 |
0.64% |
Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
421 |
$103,098.69 |
0.61% |
Intra-Cellular Therapies, Inc. |
ITCI |
46116X101 |
Biotechnology |
1,207 |
$103,427.83 |
0.61% |
Vericel Corporation |
VCEL |
92346J108 |
Biotechnology |
1,713 |
$101,255.43 |
0.60% |
Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
1,347 |
$96,606.84 |
0.57% |
Roivant Sciences Ltd. |
ROIV |
G76279101 |
Biotechnology |
7,233 |
$90,629.49 |
0.54% |
ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
5,336 |
$87,350.32 |
0.52% |
Avidity Biosciences, Inc. |
RNA |
05370A108 |
Biotechnology |
2,011 |
$86,975.75 |
0.52% |
Blueprint Medicines Corporation |
BPMC |
09627Y109 |
Pharmaceuticals |
926 |
$87,182.90 |
0.52% |
Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
10,215 |
$85,703.85 |
0.51% |
Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
453 |
$86,251.20 |
0.51% |
Twist Bioscience Corporation |
TWST |
90184D100 |
Biotechnology |
2,046 |
$86,402.58 |
0.51% |
Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
1,157 |
$84,634.55 |
0.50% |
Kymera Therapeutics, Inc. |
KYMR |
501575104 |
Biotechnology |
1,829 |
$82,268.42 |
0.49% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
178 |
$80,272.66 |
0.48% |
Exact Sciences Corporation |
EXAS |
30063P105 |
Biotechnology |
1,434 |
$75,872.94 |
0.45% |
Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Biotechnology |
652 |
$74,477.96 |
0.44% |
Viking Therapeutics, Inc. |
VKTX |
92686J106 |
Biotechnology |
1,380 |
$72,574.20 |
0.43% |
BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
1,089 |
$69,979.14 |
0.42% |
US Dollar |
$USD |
|
Other |
69,750 |
$69,750.36 |
0.41% |
Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
1,855 |
$63,088.55 |
0.37% |
Myriad Genetics, Inc. |
MYGN |
62855J104 |
Medical Services |
3,123 |
$48,375.27 |
0.29% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|